ARCHIVES

Conference Level For NCI Is 5.4% Over FY 1990

This article is from The Cancer Letter archive.

Vol. 16 No. 42 | November 2, 1990

Download PDF Visit The Full Archive

Related Articles

Alan Rabson Named Acting NCI Director

October 5, 2001

ACS President Huerta Disagrees With Staff On Cell Phone Danger.

August 1, 2008

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

In Brief: Two New Section Chiefs Named In NCI Research Contracts Branch; S. 988 Markup Set For April 25

April 18, 1980

FDA Adopts Final Diagnostics X-Ray Rule Amendment

September 9, 1977